Publications scientifiques Bordet

Publications scientifiques Bordet

  • Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol.

  • Auteurs Grimbergen G, Eijkelenkamp H, Snoeren LMW, Bahij R, Bernchou U, van der Bijl E, Heerkens HD, Binda S, Ng SSW, Bouchart C, Paquier Z, Brown K, Khor R, Chuter R, Freear L, Dunlop A, Mitchell RA, Erickson BA, Hall WA, Godoy Scripes P, Tyagi N, de Leon J, Tran C, Oh S, Renz P, Shessel A, Taylor E, Intven MPW, Meijer GJ
  • Auteurs (entité) BOUCHART CHRISTELLE
  • Revue Clin Transl Radiat Oncol
  • Date de publication 2024-07
Treatment planning for MR-guided SBRT of pancreatic tumors on a 1.5 T MR-Linac: A global consensus protocol.
  • External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

  • Auteurs Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A
  • Auteurs (entité) DIAMAND ROMAIN
  • Revue World J Urol
  • Date de publication 2024-06
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
  • External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

  • Auteurs Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A
  • Auteurs (entité) BOURGENO HENRI-ALEXANDRE
  • Revue World J Urol
  • Date de publication 2024-06
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
  • External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

  • Auteurs Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A
  • Auteurs (entité) BAUDEWYNS ARTHUR
  • Revue World J Urol
  • Date de publication 2024-06
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
  • External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

  • Auteurs Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A
  • Auteurs (entité) LEFEBVRE YOLENE
  • Revue World J Urol
  • Date de publication 2024-06
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
  • External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.

  • Auteurs Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A
  • Auteurs (entité) PELTIER ALEXANDRE
  • Revue World J Urol
  • Date de publication 2024-06
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
  • Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.

  • Auteurs Moreau P, Hulin C, Perrot A, Arnulf B, Belhadj K, Benboubker L, Zweegman S, Caillon H, Caillot D, Avet-Loiseau H, Delforge M, Dejoie T, Facon T, Sonntag C, Fontan J, Mohty M, Jie KS, Karlin L, Kuhnowski F, Lambert J, Leleu X, Macro M, Orsini-Piocelle F, Roussel M, Schiano de Colella JM, van de Donk NW, Wuillème S, Broijl A, Touzeau C, Tiab M, Marolleau JP, Meuleman N, Vekemans MC, Westerman M, Klein SK, Levin MD, Offner F, Escoffre-Barbe M, Eveillard JR, Garidi R, Hua W, Wang J, Tuozzo A, de Boer C, Rowe M, Vanquickelberghe V, Carson R, Vermeulen J, Corre J, Sonneveld P
  • Auteurs (entité) MEULEMAN NATHALIE
  • Revue Lancet Oncol
  • Date de publication 2024-06
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial.
  • EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe.

  • Auteurs Ignatiadis M, Poulakaki F, Spanic T, Brain E, Lacombe D, Sonke GS, Vincent-Salomon A, Van Duijnhoven F, Meattini I, Kaidar-Person O, Aftimos P, Lecouvet F, Cardoso F, Retèl VP, Cameron D
  • Auteurs (entité) IGNATIADIS MICHAIL
  • Revue Eur J Cancer
  • Date de publication 2024-06
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe.
Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet